TD Private Client Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.9K | Sell |
1,695
-32
| -2% | -$735 | ﹤0.01% | 885 |
|
|
2025
Q1 | $50.1K | Sell |
1,727
-372
| -18% | -$10.8K | ﹤0.01% | 811 |
|
|
2024
Q4 | $77.9K | Buy |
2,099
+388
| +23% | +$14.4K | ﹤0.01% | 749 |
|
|
2024
Q3 | $83K | Buy |
1,711
+39
| +2% | +$1.89K | ﹤0.01% | 740 |
|
|
2024
Q2 | $66.9K | Buy |
1,672
+16
| +1% | +$640 | ﹤0.01% | 755 |
|
|
2024
Q1 | $72.7K | Buy |
1,656
+412
| +33% | +$18.1K | ﹤0.01% | 747 |
|
|
2023
Q4 | $76.9K | Buy |
1,244
+208
| +20% | +$12.9K | ﹤0.01% | 733 |
|
|
2023
Q3 | $47.6K | Hold |
1,036
| – | – | ﹤0.01% | 777 |
|
|
2023
Q2 | $59.5K | Buy |
1,036
+428
| +70% | +$24.6K | ﹤0.01% | 747 |
|
|
2023
Q1 | $22.8K | Buy |
608
+119
| +24% | +$4.46K | ﹤0.01% | 921 |
|
|
2022
Q4 | $13.7K | Sell |
489
-120
| -20% | -$3.36K | ﹤0.01% | 968 |
|
|
2022
Q3 | $17.1K | Hold |
609
| – | – | ﹤0.01% | 933 |
|
|
2022
Q2 | $21.2K | Buy |
609
+173
| +40% | +$6.02K | ﹤0.01% | 909 |
|
|
2022
Q1 | $15.7K | Buy |
+436
| New | +$15.7K | ﹤0.01% | 983 |
|